Bird Flu Market - Comprehensive Study Report & Recent Trends (2024-2032)

Bird Flu Market Synopsis:

Bird Flu Market Size Was Valued at USD 1.45 Billion in 2023 and is Projected to Reach USD 2.31 Billion by 2032, Growing at a CAGR of 5.3 % From 2024-2032.

Bird Flu Market also called the Avian Influenza Market deals with economic activity revolving around the diagnosis, protection, vaccine, and medical management of bird flu – a viral disease. Avian influenza is a contagious viral disease affecting principally birds, though it may extend to humans and animals with profoundly damaging health impacts. The market comprises diagnostic tools, antiviral products, vaccines and quarantine; biosecurity agents; surveillance and monitoring; and R&D. The factors having an impact on this market include rising incidences in poultry, growing concern related to disease transmission from animals to human body, and requirement for effective disease control measures to prevent future outbreaks on the human population.

Cat classification concerns a broad range of solutions designed to prevent and control birdflu – an influenza virus that primarily affects birds but can also infect people and other animals.. Inputs related diagnostic equipment, Vaccines, anti viral drugs, bio security measures and reasearches aimed at illnesses control and eradication fall under this market. A combination of the following factors is considered as important drivers: High domestic and global concerns about zoonotic diseases, all-rounded disturbances caused by avian influenza periodically affecting the poultry business and threatening the health of humanity. There is, therefore, an increasing need for fast-accessible diagnostic facilities for birds samples, particularly the H5N1 and H7N9 subtypes. Vaccines are also developed as scientists strive to produce better vaccines to cope with the new various mutated viruses. Supporting this demand is funding by governments and a trend toward larger financial contributions for avian flu research encouraged by the consideration of pandemic threats

One important factor influencing this industry is technological improvements. For instance, the incorporation of molecular diagnostics has enhanced early detection capabilities, enabled the quick isolation of diseased birds and lowering the rates of transmission. Recombinant DNA technology and other innovations in vaccine development are also contributing to increased efficacy and shortened production timelines, both of which are critical in outbreak situations. The development of tracking and surveillance systems that allow for real-time monitoring of avian influenza in areas where the disease is most prevalent, along with biosecurity measures, further supports market expansion. Businesses in this industry are placing a high priority on R&D expenditures for vaccines and novel treatment alternatives that can withstand upcoming epidemics and possible mutations. Furthermore, tighter government regulations and increased regulatory support are hurting industry expansion.

Bird Flu Market Trend Analysis:

Increasing Demand for Rapid Diagnostic Tools and Point-of-Care Testing

• The increasing need for point-of-care testing solutions and quick diagnostic tools is a major trend in the bird flu market. Early detection is now essential for the successful containment and treatment of avian influenza since it continues to pose a hazard to the health of both humans and animals. Response times for managing epidemics may be delayed by the time-consuming and laboratory-required nature of traditional diagnostic procedures. As a result, rapid diagnostic tools—like molecular testing kits—that can yield results in a matter of minutes or hours as opposed to days have become increasingly popular. Additionally, point-of-care testing (POCT) solutions are becoming more popular, particularly in areas with high rates of avian flu and healthcare infrastructure. POCT technologies enable diagnostics to be performed directly at the site of an outbreak.

Expanding Market Potential in Vaccination and Immunization Programs

• One of the developing trends in the Bird Flu Market is the growth of additional vaccinations and immunizations, aiming at frequent avian flu-hit nations including South East Asia, Africa as well as South America. Consequently, there appears a growing need for vaccines that can help sustain the global poultry business and protect birds numerous of which are affected by avian influenza. This demand generates a favorable market for vaccine producers especially those using advanced technologies for the production of better vaccines to the newly identified avian flu strains. Governing authorities and policy-making bodies, international organizations and private companies, and corporate houses are spending on R & D so that more effective and long-lasting protective vaccines are evolved for the existing as well as probable emerging strains. The expectations are that next-generation vaccine platforms including recombinant DNA as well as vector-based will take root because, with such technologies, the process of vaccine development is faster, thus, adapting to different strains is easier. Further, this opportunity is complemented by increasing government backing, as authorities in key developed countries are implementing policies that would ensure widespread vaccination in vulnerable regions to curb the risk of zoonotic disease spillover. Moreover, public awareness created by international organizations, as well as subsidies and grants for local poultry farmers are stimulating the need for vaccine programs. Bird Flu Market Segmented based on Virus type, Test type, and Treatment type

By Virus Type, H5N1 segment is expected to dominate the market during the forecast period

• It is expected that during the Bird Flu duration for the period of forecast, the H5N1 virus type segment will have a large portion of the type due to its high pathogenicity as well as its deadly effects to birds and humans. Originally discovered in Italy dating back to 1999, the H5N1 strain is one of the best-characterized subtypes of avian influenza thanks to its highly pathogenic effects on both keepers of avians and other creatures, in addition to persons who contracted the virus. Poultry farming has suffered badly from these losses chiefly caused by this virus strain specifically in Southeast Asia and some parts of Africa. Therefore, the market has significant demand for H5N1-specific diagnostic kits, vaccines, and anti-viral drugs making this segment of the market the most significant. H5N1 remains the focus of efforts by governments and international organizations that provide funding for specific vaccines, rapid diagnostics, and efficient biosecurity measures.

By Test Type, the PCR-Based Testing segment expected to held the largest share

• The PCR-based testing segment is projected to hold the largest share in the Bird Flu Market by test type, primarily due to its high accuracy, sensitivity, and speed in detecting avian influenza strains. Polymerase chain reaction (PCR) testing is considered the gold standard for diagnosing viral infections, including bird flu, as it can identify specific viral genetic material even at low levels, allowing for early detection of infections. This early detection capability is especially crucial in preventing the spread of avian influenza in both poultry and human populations. PCR-based testing is widely adopted in diagnostic laboratories and increasingly available at point-of-care settings, as advancements in PCR technology have led to portable, user-friendly devices suited for on-site testing.

Bird Flu Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast Period.

• North America is anticipated to hold the largest Bird Flu Market size throughout the forecast period due to well-developed healthcare facilities, strong legal backing, and heightened knowledge of Avian Influenza and other zoonotic illnesses.. The focus on early diagnosis and control measures, biosecurity, and prevention-oriented strategies for health care of bird flu has resulted in increased stakes in the diagnosis of avian flu, vaccines and treatment. The United States for instance can boast of a fairly good monitoring and combating of avian influenza breakouts through institutions such as the Centres for Disease Control and Prevention (CDC) as well as the U.S. Department of Agriculture (USDA). They work closely with the local health departments when implementing strict measures and funding vaccines and diagnostics, which explains why North America leads the market.
• The North American Bird Flu Market enjoys consistent research and development and monitory funding towards bird flu outbreaks and health crises. Players in the region are directing their attention to better diagnostic solutions, including PCR-based and rapid testing kits as well as the more efficient and flexible next-generation vaccines. Further, increased consumer concern as well as legislative requirements concerning food processing and animal husbandry standards positively influence the demand for biosafety solutions among the U.S. and Canada-based poultry farms. Due to the favourable healthcare policies available in the region, technology development, and early preparedness in managing bird flu risks, North America possesses massive growth opportunities to continue dominating the Bird Flu Market during the course of the forecast period.

Active Key Players in the Bird Flu Market:

• Abbott Laboratories (United States)
• Boehringer Ingelheim International GmbH (Germany)
• Cipla Inc. (India)
• Elanco Animal Health Incorporated (United States)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• GlaxoSmithKline plc (United Kingdom)
• Merck & Co., Inc. (United States)
• Nexvet Biopharma (Ireland)
• Novartis International AG (Switzerland)
• Pfizer Inc. (United States)
• Sanofi S.A. (France)
• Sequent Scientific Ltd. (India)
• Sinovac Biotech Ltd. (China)
• Virbac (France)
• Zoetis Inc. (United States)
• Other Active Players

Key Industry Developments in the Bird Flu Market:

• In August 2023, The Biomedical Advanced Research and Development Authority (BARDA), a division of the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services, chose CSL
• In April 2023, to combat the most recent epidemic of highly pathogenic avian influenza (HPAI) in the United States, the U.S. Department of Agriculture (USDA) is working on a number of fronts. This widespread virus usually peaks in the spring and summer and is conveyed by migratory wild birds,

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Bird Flu Market by Virus Type
 4.1 Bird Flu Market Snapshot and Growth Engine
 4.2 Bird Flu Market Overview
 4.3 H5N1
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 H5N1: Geographic Segmentation Analysis
 4.4 H7N9
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 H7N9: Geographic Segmentation Analysis
 4.5 H5N6
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 H5N6: Geographic Segmentation Analysis
 4.6 H5N8
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 H5N8: Geographic Segmentation Analysis
 4.7 H10N8
  4.7.1 Introduction and Market Overview
  4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.7.3 Key Market Trends, Growth Factors and Opportunities
  4.7.4 H10N8: Geographic Segmentation Analysis
 4.8 H9N2
  4.8.1 Introduction and Market Overview
  4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.8.3 Key Market Trends, Growth Factors and Opportunities
  4.8.4 H9N2: Geographic Segmentation Analysis
 4.9 and Others
  4.9.1 Introduction and Market Overview
  4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.9.3 Key Market Trends, Growth Factors and Opportunities
  4.9.4 and Others: Geographic Segmentation Analysis

Chapter 5: Bird Flu Market by Test Type
 5.1 Bird Flu Market Snapshot and Growth Engine
 5.2 Bird Flu Market Overview
 5.3 PCR Tests
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 PCR Tests: Geographic Segmentation Analysis
 5.4 ELISA Tests
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 ELISA Tests: Geographic Segmentation Analysis
 5.5 Hemagglutination Assays
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Hemagglutination Assays: Geographic Segmentation Analysis
 5.6 Virus Isolation Tests
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Virus Isolation Tests: Geographic Segmentation Analysis
 5.7 Next Generation Sequencing
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Next Generation Sequencing: Geographic Segmentation Analysis
 5.8 Others
  5.8.1 Introduction and Market Overview
  5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.8.3 Key Market Trends, Growth Factors and Opportunities
  5.8.4 Others: Geographic Segmentation Analysis

Chapter 6: Bird Flu Market by Treatment Type
 6.1 Bird Flu Market Snapshot and Growth Engine
 6.2 Bird Flu Market Overview
 6.3 Vaccines
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Vaccines: Geographic Segmentation Analysis
 6.4 Antiviral Medication
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Antiviral Medication: Geographic Segmentation Analysis
 6.5 Immunomodulators
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Immunomodulators: Geographic Segmentation Analysis
 6.6 Others
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Others: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Bird Flu Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions  
 7.2 ABBOTT LABORATORIES (UNITED STATES)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (GERMANY)
 7.4 CIPLA INC. (INDIA)
 7.5 ELANCO ANIMAL HEALTH INCORPORATED (UNITED STATES)
 7.6 F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND)
 7.7 GLAXOSMITHKLINE PLC (UNITED KINGDOM)
 7.8 MERCK & CO. INC. (UNITED STATES)
 7.9 NEXVET BIOPHARMA (IRELAND)
 7.10 NOVARTIS INTERNATIONAL AG (SWITZERLAND)
 7.11 PFIZER INC. (UNITED STATES)
 7.12 SANOFI S.A. (FRANCE)
 7.13 SEQUENT SCIENTIFIC LTD. (INDIA)
 7.14 SINOVAC BIOTECH LTD. (CHINA)
 7.15 VIRBAC (FRANCE)
 7.16 ZOETIS INC. (UNITED STATES)
 7.17 OTHER ACTIVE PLAYERS

Chapter 8: Global Bird Flu Market By Region
 8.1 Overview
 8.2. North America Bird Flu Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Virus Type
  8.2.4.1 H5N1
  8.2.4.2 H7N9
  8.2.4.3 H5N6
  8.2.4.4 H5N8
  8.2.4.5 H10N8
  8.2.4.6 H9N2
  8.2.4.7 and Others
  8.2.5 Historic and Forecasted Market Size By Test Type
  8.2.5.1 PCR Tests
  8.2.5.2 ELISA Tests
  8.2.5.3 Hemagglutination Assays
  8.2.5.4 Virus Isolation Tests
  8.2.5.5 Next Generation Sequencing
  8.2.5.6 Others
  8.2.6 Historic and Forecasted Market Size By Treatment Type
  8.2.6.1 Vaccines
  8.2.6.2 Antiviral Medication
  8.2.6.3 Immunomodulators
  8.2.6.4 Others
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Bird Flu Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Virus Type
  8.3.4.1 H5N1
  8.3.4.2 H7N9
  8.3.4.3 H5N6
  8.3.4.4 H5N8
  8.3.4.5 H10N8
  8.3.4.6 H9N2
  8.3.4.7 and Others
  8.3.5 Historic and Forecasted Market Size By Test Type
  8.3.5.1 PCR Tests
  8.3.5.2 ELISA Tests
  8.3.5.3 Hemagglutination Assays
  8.3.5.4 Virus Isolation Tests
  8.3.5.5 Next Generation Sequencing
  8.3.5.6 Others
  8.3.6 Historic and Forecasted Market Size By Treatment Type
  8.3.6.1 Vaccines
  8.3.6.2 Antiviral Medication
  8.3.6.3 Immunomodulators
  8.3.6.4 Others
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Russia
  8.3.7.2 Bulgaria
  8.3.7.3 The Czech Republic
  8.3.7.4 Hungary
  8.3.7.5 Poland
  8.3.7.6 Romania
  8.3.7.7 Rest of Eastern Europe
 8.4. Western Europe Bird Flu Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Virus Type
  8.4.4.1 H5N1
  8.4.4.2 H7N9
  8.4.4.3 H5N6
  8.4.4.4 H5N8
  8.4.4.5 H10N8
  8.4.4.6 H9N2
  8.4.4.7 and Others
  8.4.5 Historic and Forecasted Market Size By Test Type
  8.4.5.1 PCR Tests
  8.4.5.2 ELISA Tests
  8.4.5.3 Hemagglutination Assays
  8.4.5.4 Virus Isolation Tests
  8.4.5.5 Next Generation Sequencing
  8.4.5.6 Others
  8.4.6 Historic and Forecasted Market Size By Treatment Type
  8.4.6.1 Vaccines
  8.4.6.2 Antiviral Medication
  8.4.6.3 Immunomodulators
  8.4.6.4 Others
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 The Netherlands
  8.4.7.5 Italy
  8.4.7.6 Spain
  8.4.7.7 Rest of Western Europe
 8.5. Asia Pacific Bird Flu Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Virus Type
  8.5.4.1 H5N1
  8.5.4.2 H7N9
  8.5.4.3 H5N6
  8.5.4.4 H5N8
  8.5.4.5 H10N8
  8.5.4.6 H9N2
  8.5.4.7 and Others
  8.5.5 Historic and Forecasted Market Size By Test Type
  8.5.5.1 PCR Tests
  8.5.5.2 ELISA Tests
  8.5.5.3 Hemagglutination Assays
  8.5.5.4 Virus Isolation Tests
  8.5.5.5 Next Generation Sequencing
  8.5.5.6 Others
  8.5.6 Historic and Forecasted Market Size By Treatment Type
  8.5.6.1 Vaccines
  8.5.6.2 Antiviral Medication
  8.5.6.3 Immunomodulators
  8.5.6.4 Others
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Bird Flu Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Virus Type
  8.6.4.1 H5N1
  8.6.4.2 H7N9
  8.6.4.3 H5N6
  8.6.4.4 H5N8
  8.6.4.5 H10N8
  8.6.4.6 H9N2
  8.6.4.7 and Others
  8.6.5 Historic and Forecasted Market Size By Test Type
  8.6.5.1 PCR Tests
  8.6.5.2 ELISA Tests
  8.6.5.3 Hemagglutination Assays
  8.6.5.4 Virus Isolation Tests
  8.6.5.5 Next Generation Sequencing
  8.6.5.6 Others
  8.6.6 Historic and Forecasted Market Size By Treatment Type
  8.6.6.1 Vaccines
  8.6.6.2 Antiviral Medication
  8.6.6.3 Immunomodulators
  8.6.6.4 Others
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkiye
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Bird Flu Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Virus Type
  8.7.4.1 H5N1
  8.7.4.2 H7N9
  8.7.4.3 H5N6
  8.7.4.4 H5N8
  8.7.4.5 H10N8
  8.7.4.6 H9N2
  8.7.4.7 and Others
  8.7.5 Historic and Forecasted Market Size By Test Type
  8.7.5.1 PCR Tests
  8.7.5.2 ELISA Tests
  8.7.5.3 Hemagglutination Assays
  8.7.5.4 Virus Isolation Tests
  8.7.5.5 Next Generation Sequencing
  8.7.5.6 Others
  8.7.6 Historic and Forecasted Market Size By Treatment Type
  8.7.6.1 Vaccines
  8.7.6.2 Antiviral Medication
  8.7.6.3 Immunomodulators
  8.7.6.4 Others
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research